Dimensional Fund Advisors
TBPH icon

Dimensional Fund Advisors’s Theravance Biopharma TBPH Stock Holding History

Dimensional Fund Advisors’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.7M Buy
1,043,051
+59,436
+6% +$984K ﹤0.01% 2094
2026
Q1 		$16M Buy
983,615
+124,658
+15% +$2.21M ﹤0.01% 2077
2025
Q4 		$16.1M Buy
858,957
+92,253
+12% +$1.53M ﹤0.01% 2086
2025
Q3 		$11.2M Buy
766,704
+44,634
+6% +$564K ﹤0.01% 2263
2025
Q2 		$7.97M Buy
722,070
+78,232
+12% +$761K ﹤0.01% 2358
2025
Q1 		$5.75M Buy
643,838
+90,125
+16% +$839K ﹤0.01% 2459
2024
Q4 		$5.21M Buy
553,713
+95,304
+21% +$867K ﹤0.01% 2519
2024
Q3 		$3.69M Buy
458,409
+128,228
+39% +$1.11M ﹤0.01% 2611
2024
Q2 		$2.8M Buy
330,181
+91,679
+38% +$827K ﹤0.01% 2672
2024
Q1 		$2.14M Buy
238,502
+105,318
+79% +$976K ﹤0.01% 2780
2023
Q4 		$1.5M Buy
133,184
+61,564
+86% +$620K ﹤0.01% 2849
2023
Q3 		$617K Buy
71,620
+16
+0% +$154 ﹤0.01% 3020
2023
Q2 		$741K Buy
+71,604
New +$791K ﹤0.01% 2985
2016
Q4 		– Sell
-43,018
Closed -$1.56M – 3301
2016
Q3 		$1.56M Hold
43,018
– – ﹤0.01% 2841
2016
Q2 		$976K Sell
43,018
-474
-1% -$10.2K ﹤0.01% 2931
2016
Q1 		$817K Sell
43,492
-30
-0.1% -$491 ﹤0.01% 2961
2015
Q4 		$713K Buy
43,522
+20,004
+85% +$317K ﹤0.01% 3028
2015
Q3 		$258K Sell
23,518
-1,088
-4% -$13.9K ﹤0.01% 3212
2015
Q2 		$320K Sell
24,606
-4,472
-15% -$69.4K ﹤0.01% 3199
2015
Q1 		$505K Sell
29,078
-27
-0.1% -$495 ﹤0.01% 3101
2014
Q4 		$434K Sell
29,105
-15
-0.1% -$261 ﹤0.01% 3154
2014
Q3 		$671K Hold
29,120
– – ﹤0.01% 3098
2014
Q2 		$929K Buy
+29,120
New +$877K ﹤0.01% 3051

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
ICM
Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dimensional Fund Advisors's TBPH Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Theravance Biopharma (TBPH) stake by 6% in Q2 2026, buying an estimated $984K and bringing the position to 1,043,051 shares worth $17.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2094.

Dimensional Fund Advisors first reported a position in TBPH in Q2 2014 and has held it in 23 quarters since. 181 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

  • Dimensional Fund Advisors held 1,043,051 shares of Theravance Biopharma worth $17.7M as of Q2 2026.
  • Dimensional Fund Advisors bought 59,436 Theravance Biopharma shares in Q2 2026, an estimated $984K.
  • Theravance Biopharma made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2094 holding.
  • Dimensional Fund Advisors first reported a position in Theravance Biopharma in Q2 2014 and has held it in 23 quarters since.
  • 181 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.